The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) announced executive participation in three investor conferences in March 2026. Presentations include Jefferies Healthcare Services Innovation & Technology Summit and Leerink Global Healthcare Conference on March 9 in Miami, and Oppenheimer MedTech & Services Conference (virtual) on March 16.
Presenters include Dr. Daniel Virnich, CEO, and Rob Carter, CFO; webcasts and replays will be available via the company Investor Relations site.
Positive
- None.
Negative
- None.
News Market Reaction – TOI
In the Feb 25 session, TOI gained 10.85%, reflecting a significant positive market reaction. Argus tracked a peak move of +12.9% during that session. Our momentum scanner triggered 20 alerts that day, indicating elevated trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 23 | Board appointment | Positive | -0.4% | Experienced healthcare executive appointed to TOI’s Board of Directors. |
| Jan 12 | Guidance & outlook | Positive | -7.9% | Reaffirmed 2025 guidance and provided preliminary 2026 revenue and EBITDA outlook. |
| Jan 9 | Leadership promotions | Positive | -3.0% | Promotions of CIO and CPO to support technology and people strategy. |
| Jan 2 | Board addition | Positive | +6.8% | Addition of experienced CFO from another healthcare company to the Board. |
| Dec 1 | Board resignation | Negative | -6.4% | Resignation of Board member and initiation of search for new directors. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive strategic and leadership updates have often seen mixed to negative next-day price reactions, with only some governance changes aligning with price gains.
Over the past few months, TOI has focused on governance and strategic positioning. New board members were added on Jan 2, 2026 and Feb 23, 2026, and leadership promotions were announced on Jan 9, 2026. The company also reaffirmed 2025 guidance and outlined a 2026 outlook on Jan 12, 2026. Price reactions have been mixed, with several positive-sounding updates followed by negative moves and only some board additions drawing a positive response.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will participate in several investor conferences in March.
Details for the conferences are as follows:
- Jefferies Healthcare Services Innovation & Technology Summit
Presentation: Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ET
Location: Miami, FL
Presenter: Dr. Daniel Virnich, Chief Executive Officer - Leerink Global Healthcare Conference
Presentation: Monday, March 9, 2026, from 3:00 p.m. to 3:30 p.m. ET
Location: Miami, FL
Presenter: Rob Carter, Chief Financial Officer - Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Presentation: Monday, March 16, 2026, from 10:00 a.m. to 10:30 a.m. ET
Location: Virtual
Presenters: Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer
Where available, live webcasts and replays of the presentations will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
